Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-14

Clinical Trial Update: mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating mFOLFOX6 chemotherapy combined with apatinib as postoperative treatment in high-risk colorectal cancer (Stage IIIB/IIIC) has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apatinib (apatinib)
  • MFOLFOX6

Snippet

Sponsor: Huashan Hospital | Conditions: Apatinib | Phase 3 | Status: COMPLETED